Evolus Inc announces two peer review studies published in Aesthetic Surgery Journal that provide supportive evidence of the safety and efficacy of repeat doses of prabotulinumtoxinA (Jeuveau) to decrease the appearance of moderate to severe glabellar lines, also known as frown lines between the eyes.